The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Medical Wound Care Biologics Market Research Report 2025

Global Medical Wound Care Biologics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1796554

No of Pages : 101

Synopsis
Medical wound care biologics are products derived from biological sources that are used in the treatment of wounds to promote healing and tissue regeneration. These biologics are typically composed of living cells, proteins, growth factors, or other biologically active substances that are applied to the wound to facilitate the healing process.
Global Medical Wound Care Biologics market is projected to reach US$ 7948.2 million in 2029, increasing from US$ 3940 million in 2022, with the CAGR of 10.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Wound Care Biologics market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Wound Care Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Smith & Nephew Plc
Stryker Corporation
MIMEDX
Organogenesis
Bioventus
Skye Biologics
Anika Therapeutics
Alphatec Holdings
Kerecis
Integra LifeSciences
Orthocell
3M Company
Convatec Group
Coloplast
Cardinal Health
Mölnlycke
Segment by Type
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Segment by Application
Acute Wounds
Chronic Wounds
Surgical Wounds
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Medical Wound Care Biologics report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Wound Care Biologics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Biologic Skin Substitutes
1.2.3 Enzyme Based Formulations
1.2.4 Growth Factors
1.3 Market by Application
1.3.1 Global Medical Wound Care Biologics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Acute Wounds
1.3.3 Chronic Wounds
1.3.4 Surgical Wounds
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical Wound Care Biologics Market Perspective (2018-2029)
2.2 Medical Wound Care Biologics Growth Trends by Region
2.2.1 Global Medical Wound Care Biologics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medical Wound Care Biologics Historic Market Size by Region (2018-2023)
2.2.3 Medical Wound Care Biologics Forecasted Market Size by Region (2024-2029)
2.3 Medical Wound Care Biologics Market Dynamics
2.3.1 Medical Wound Care Biologics Industry Trends
2.3.2 Medical Wound Care Biologics Market Drivers
2.3.3 Medical Wound Care Biologics Market Challenges
2.3.4 Medical Wound Care Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Wound Care Biologics Players by Revenue
3.1.1 Global Top Medical Wound Care Biologics Players by Revenue (2018-2023)
3.1.2 Global Medical Wound Care Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Medical Wound Care Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical Wound Care Biologics Revenue
3.4 Global Medical Wound Care Biologics Market Concentration Ratio
3.4.1 Global Medical Wound Care Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Wound Care Biologics Revenue in 2022
3.5 Medical Wound Care Biologics Key Players Head office and Area Served
3.6 Key Players Medical Wound Care Biologics Product Solution and Service
3.7 Date of Enter into Medical Wound Care Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Wound Care Biologics Breakdown Data by Type
4.1 Global Medical Wound Care Biologics Historic Market Size by Type (2018-2023)
4.2 Global Medical Wound Care Biologics Forecasted Market Size by Type (2024-2029)
5 Medical Wound Care Biologics Breakdown Data by Application
5.1 Global Medical Wound Care Biologics Historic Market Size by Application (2018-2023)
5.2 Global Medical Wound Care Biologics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medical Wound Care Biologics Market Size (2018-2029)
6.2 North America Medical Wound Care Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medical Wound Care Biologics Market Size by Country (2018-2023)
6.4 North America Medical Wound Care Biologics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical Wound Care Biologics Market Size (2018-2029)
7.2 Europe Medical Wound Care Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medical Wound Care Biologics Market Size by Country (2018-2023)
7.4 Europe Medical Wound Care Biologics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical Wound Care Biologics Market Size (2018-2029)
8.2 Asia-Pacific Medical Wound Care Biologics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medical Wound Care Biologics Market Size by Region (2018-2023)
8.4 Asia-Pacific Medical Wound Care Biologics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical Wound Care Biologics Market Size (2018-2029)
9.2 Latin America Medical Wound Care Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medical Wound Care Biologics Market Size by Country (2018-2023)
9.4 Latin America Medical Wound Care Biologics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Wound Care Biologics Market Size (2018-2029)
10.2 Middle East & Africa Medical Wound Care Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medical Wound Care Biologics Market Size by Country (2018-2023)
10.4 Middle East & Africa Medical Wound Care Biologics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Smith & Nephew Plc
11.1.1 Smith & Nephew Plc Company Detail
11.1.2 Smith & Nephew Plc Business Overview
11.1.3 Smith & Nephew Plc Medical Wound Care Biologics Introduction
11.1.4 Smith & Nephew Plc Revenue in Medical Wound Care Biologics Business (2018-2023)
11.1.5 Smith & Nephew Plc Recent Development
11.2 Stryker Corporation
11.2.1 Stryker Corporation Company Detail
11.2.2 Stryker Corporation Business Overview
11.2.3 Stryker Corporation Medical Wound Care Biologics Introduction
11.2.4 Stryker Corporation Revenue in Medical Wound Care Biologics Business (2018-2023)
11.2.5 Stryker Corporation Recent Development
11.3 MIMEDX
11.3.1 MIMEDX Company Detail
11.3.2 MIMEDX Business Overview
11.3.3 MIMEDX Medical Wound Care Biologics Introduction
11.3.4 MIMEDX Revenue in Medical Wound Care Biologics Business (2018-2023)
11.3.5 MIMEDX Recent Development
11.4 Organogenesis
11.4.1 Organogenesis Company Detail
11.4.2 Organogenesis Business Overview
11.4.3 Organogenesis Medical Wound Care Biologics Introduction
11.4.4 Organogenesis Revenue in Medical Wound Care Biologics Business (2018-2023)
11.4.5 Organogenesis Recent Development
11.5 Bioventus
11.5.1 Bioventus Company Detail
11.5.2 Bioventus Business Overview
11.5.3 Bioventus Medical Wound Care Biologics Introduction
11.5.4 Bioventus Revenue in Medical Wound Care Biologics Business (2018-2023)
11.5.5 Bioventus Recent Development
11.6 Skye Biologics
11.6.1 Skye Biologics Company Detail
11.6.2 Skye Biologics Business Overview
11.6.3 Skye Biologics Medical Wound Care Biologics Introduction
11.6.4 Skye Biologics Revenue in Medical Wound Care Biologics Business (2018-2023)
11.6.5 Skye Biologics Recent Development
11.7 Anika Therapeutics
11.7.1 Anika Therapeutics Company Detail
11.7.2 Anika Therapeutics Business Overview
11.7.3 Anika Therapeutics Medical Wound Care Biologics Introduction
11.7.4 Anika Therapeutics Revenue in Medical Wound Care Biologics Business (2018-2023)
11.7.5 Anika Therapeutics Recent Development
11.8 Alphatec Holdings
11.8.1 Alphatec Holdings Company Detail
11.8.2 Alphatec Holdings Business Overview
11.8.3 Alphatec Holdings Medical Wound Care Biologics Introduction
11.8.4 Alphatec Holdings Revenue in Medical Wound Care Biologics Business (2018-2023)
11.8.5 Alphatec Holdings Recent Development
11.9 Kerecis
11.9.1 Kerecis Company Detail
11.9.2 Kerecis Business Overview
11.9.3 Kerecis Medical Wound Care Biologics Introduction
11.9.4 Kerecis Revenue in Medical Wound Care Biologics Business (2018-2023)
11.9.5 Kerecis Recent Development
11.10 Integra LifeSciences
11.10.1 Integra LifeSciences Company Detail
11.10.2 Integra LifeSciences Business Overview
11.10.3 Integra LifeSciences Medical Wound Care Biologics Introduction
11.10.4 Integra LifeSciences Revenue in Medical Wound Care Biologics Business (2018-2023)
11.10.5 Integra LifeSciences Recent Development
11.11 Orthocell
11.11.1 Orthocell Company Detail
11.11.2 Orthocell Business Overview
11.11.3 Orthocell Medical Wound Care Biologics Introduction
11.11.4 Orthocell Revenue in Medical Wound Care Biologics Business (2018-2023)
11.11.5 Orthocell Recent Development
11.12 3M Company
11.12.1 3M Company Company Detail
11.12.2 3M Company Business Overview
11.12.3 3M Company Medical Wound Care Biologics Introduction
11.12.4 3M Company Revenue in Medical Wound Care Biologics Business (2018-2023)
11.12.5 3M Company Recent Development
11.13 Convatec Group
11.13.1 Convatec Group Company Detail
11.13.2 Convatec Group Business Overview
11.13.3 Convatec Group Medical Wound Care Biologics Introduction
11.13.4 Convatec Group Revenue in Medical Wound Care Biologics Business (2018-2023)
11.13.5 Convatec Group Recent Development
11.14 Coloplast
11.14.1 Coloplast Company Detail
11.14.2 Coloplast Business Overview
11.14.3 Coloplast Medical Wound Care Biologics Introduction
11.14.4 Coloplast Revenue in Medical Wound Care Biologics Business (2018-2023)
11.14.5 Coloplast Recent Development
11.15 Cardinal Health
11.15.1 Cardinal Health Company Detail
11.15.2 Cardinal Health Business Overview
11.15.3 Cardinal Health Medical Wound Care Biologics Introduction
11.15.4 Cardinal Health Revenue in Medical Wound Care Biologics Business (2018-2023)
11.15.5 Cardinal Health Recent Development
11.16 Mölnlycke
11.16.1 Mölnlycke Company Detail
11.16.2 Mölnlycke Business Overview
11.16.3 Mölnlycke Medical Wound Care Biologics Introduction
11.16.4 Mölnlycke Revenue in Medical Wound Care Biologics Business (2018-2023)
11.16.5 Mölnlycke Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’